10
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Cloning of a cDNA Encoding an Isoform of Human Protein Phosphatase Inhibitor 2 from Vascularized Breast Tumor

&
Pages 515-518 | Received 16 Sep 2000, Published online: 11 Jul 2009

References

  • Cohen P. The structure and regulation of protein phosphatases. Annual Review of Biochemistry 1989; 58: 453–508
  • Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasis. Nature 1989; 339: 58–61
  • Gasparini G., Harris A.L. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clinical Oncology 1995; 13(3)765–782
  • Hayes D.F., Henderson I.C., Shaprio DL. Treatment of metastatic breast cancer: present and future prospects. Seminars in Oncology 1995; 22(2 suppl 5)5–19
  • Helps N.R., Street A.J., Elledge S.J., Cohen P.T.W. Cloning of the complete coding region for human protein phosphatase inhibitor 2 using the two hybrid system and expression of inhibitor 2 in E, coli. FEBS Letters 1994; 340: 93–98
  • Huang F.L., Glinsmann W.H. Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. European Journal of Biochemistry 1976; 70(2)419–6
  • Riedy M.C., Timm E.A., Stewart C.C. Quantitative RT-PCR for measuring gene expression. Biotechniques 1995; 18(1)70–74
  • Rompf R., Kahl G. mRNA differential display in agarose gels. Biotechniques 1997; 23(1)28–32
  • Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning 2nd edition. Published by Cold Spring Harbor Laboratory Press. 1989
  • Weidner N. Angiogenesis in breast cancer. Cancer Treatment & Research 1996; 83: 265–301
  • Wu I., Moses M.A. Cloning and expression of the cDNA encoding rat tissue inhibitor of metalloprotei-nase 3 (TIMP-3). GENE 1996; 168: 243–246
  • Wu I., Moses M.A. Molecular cloning and expression analysis of the cDNA encoding rat tissue inhibitor of metalloproteinase-4 (TIMP-4). Matrix Biology 1998; 16: 339–342

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.